rs186571865
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2
The NM_006269.2(RP1):c.616-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00608 in 1,614,088 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006269.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RP1 | NM_006269.2 | c.616-6T>C | splice_region_variant, intron_variant | ENST00000220676.2 | NP_006260.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RP1 | ENST00000220676.2 | c.616-6T>C | splice_region_variant, intron_variant | 1 | NM_006269.2 | ENSP00000220676.1 | ||||
RP1 | ENST00000637698.1 | c.616-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490104.1 | |||||
RP1 | ENST00000636932.1 | c.616-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489857.1 |
Frequencies
GnomAD3 genomes AF: 0.00442 AC: 672AN: 152184Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00505 AC: 1269AN: 251374Hom.: 6 AF XY: 0.00481 AC XY: 654AN XY: 135882
GnomAD4 exome AF: 0.00625 AC: 9132AN: 1461786Hom.: 36 Cov.: 32 AF XY: 0.00600 AC XY: 4366AN XY: 727196
GnomAD4 genome AF: 0.00443 AC: 674AN: 152302Hom.: 5 Cov.: 32 AF XY: 0.00411 AC XY: 306AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | RP1: BS1, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinitis pigmentosa Pathogenic:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Likely pathogenic, flagged submission | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2014 | - - |
Retinitis pigmentosa 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 13, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at